Adiponectin and leptin gene polymorphisms in patients with post-transplant diabetes mellitus

Pharmacogenomics

Volumn 16, Issue 11, 2015, Pages 1243-1251

  Romanowski, Maciej ^a   Dziedziejko, Violetta ^a   Maciejewska Karlowska, Agnieszka ^b   Sawczuk, Marek ^b   Safranow, Krzysztof ^a   Domanski, Leszek ^a   Pawlik, Andrzej ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF SZCZECIN   (Poland)

Author keywords

adiponectin; calcineurin inhibitors; graft; kidney; leptin; polymorphism; post transplant diabetes mellitus

Indexed keywords

ADIPONECTIN; LEPTIN; ADIPOQ PROTEIN, HUMAN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADIPONECTIN GENE; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; KIDNEY TRANSPLANTATION; LEPTIN GENE; MAJOR CLINICAL STUDY; MALE; POST TRANSPLANT DIABETES MELLITUS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ADVERSE EFFECTS; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK;

ADIPONECTIN; ADULT; ALLELES; CYCLOSPORINE; DIABETES MELLITUS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEPTIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTOPERATIVE COMPLICATIONS; RISK; TACROLIMUS;

EID: 84941614218     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.15.71     Document Type: Article

References (40)

1. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int. 62(4), 1440-1446 (2002)
2. Bee YM, Tan HC, Tay TL, Kee TY, Goh SY, Kek PC. Incidence and risk factors for development of new-onset diabetes after kidney transplantation. Ann. Acad. Med. Singapore 40(4), 160-167 (2011)
3. Iida S, Ishida H, Tokumoto T et al. New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long term impact and utility of the pre-transplant OGTT. Int. Urol. Nephrol. 42(4), 935-945 (2010)
4. Nagaraja P, Ravindran V, Morris-Stiff G, Baboolal K. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation. Transpl. Int. 26(3), 273-280 (2013)
5. Ozbay LA, Mller N, Juhl C et al. The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients. Diabet. Med. 29(12), e440-444 (2012)
6. Niu YJ, Shen ZY, Xu C et al. Establishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus in liver transplant recipients. Clin. Lab. 59(7-8), 869-874 (2013)
7. Kuo HT, Sampaio MS, Vincenti F, Bunnapradist S. Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. Am. J. Kidney Dis. 56(6), 1127-1139 (2010)
8. Sáinz N, Barrenetxe J, Moreno-Aliaga MJ, Martínez JA. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism 64(1), 35-46 (2015)
9. Martin SS, Blaha MJ, Muse ED et al. Leptin and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 239(1), 67-72 (2014)
10. Al-Azzam SI, Khabour OF, Alzoubi KH, Alzayadeen RN. The effect of leptin promoter and leptin receptor gene polymorphisms on lipid profile among the diabetic population: modulations by atorvastatin treatment and environmental factors. J. Endocrinol. Invest. 37(9), 835-842 (2014)
11. Kadowaki T, Yamauchi T, Okada-Iwabu M, Iwabu M. Adiponectin and its receptors: implications for obesity-associated diseases and longevity. Lancet Diabetes Endocrinol. 2(1), 8-9 (2014)
12. Jung CH, Kim BY, Mok JO, Kang SK, Kim CH. Association between serum adipocytokine levels and microangiopathies in patients with Type 2 diabetes mellitus. J. Diabetes Investig. 5(3), 333-339 (2014)
13. Foucan L, Maimaitiming S, Larifla L et al. Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patients. J. Diabetes Investig. 5(2), 192-198 (2014)
14. Davidson J, Wilkinson A, Dantal J et al. New-onsetdiabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 75(10 Suppl.), SS3-S24 (2003)
15. Chitnis SD, Ogasawara K, Schniedewind B, Gohh RY, Christians U, Akhlaghi F. Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. Xenobiotica 43(7), 641-649 (2013)
16. Kim YG, Ihm CG, Lee TW et al. Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation. Transplantation 93(9), 900-907 (2012)
17. Ghisdal L, Baron C, Le Meur Y et al. TCF7L2 polymorphism associates with new-onset diabetes after transplantation. J. Am. Soc. Nephrol. 20(11), 2459-2467 (2009)
18. Wang YY, Zhang M, Lu FM, Jiao Z, Qiu XY. CYP3A4 genetic polymorphisms predict cyclosporine-related clinical events in Chinese renal transplant recipients. Chin. Med. J. (Engl). 125(23), 4233-4238 (2012)
19. Sarno G, Mehta RJ, Guardado-Mendoza R, Jimenez-Ceja LM, De Rosa P, Muscogiuri G. New-onset diabetes mellitus: predictive factors and impact on the outcome of patients undergoing liver transplantation. Curr. Diabetes Rev. 9(1), 78-85 (2013)
20. Hjelmesaeth J, Jenssen T, Hagen M, Egeland T, Hartmann A. Determinants of insulin secretion after renal transplantation. Metabolism 52(5), 573-578 (2003)
21. Al-Azzam SI, Khabour OF, Alzoubi KH, Mukattash TL, Ghanma M, Saleh H. The role of adiponectin gene variants in glycemic control in patients with Type 2 diabetes. Endocr. Res. 39(1), 13-17 (2014)
22. Roszkowska-Gancarz M, Kurylowicz A, Polosak J, Mossakowska M, Franek E, Puzianowska-Kuznicka M. Functional polymorphisms of the leptin and leptin receptor genes are associated with longevity and with the risk of myocardial infarction and of Type 2 diabetes mellitus. Endokrynol. Pol. 65(1), 11-16 (2014)
23. Nicoletto BB, Souza GC, Fonseca NK et al. Association between 276G/T adiponectin gene polymorphism and new-onset diabetes after kidney transplantation. Transplantation 96(12), 1059-1064 (2013)
24. Kang ES, Magkos F, Kim BS et al. Variants of the adiponectin and adiponectin receptor-1 genes and posttransplantation diabetes mellitus in renal allograft recipients. J. Clin. Endocrinol. Metab. 97(1), E129-135 (2012)
25. Yu AR, Xin HW, Wu XC et al. Adiponectin gene polymorphisms are associated with posttransplantation diabetes mellitus in Chinese renal allograft recipients. Transplant. Proc. 43(5), 1607-1611 (2011)
26. Jaziri R, Aubert R, Roussel R et al. Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in Type 2 diabetes. Nephrol. Dial. Transplant. 25(7), 2231-2237 (2010)
27. McCaughan JA, McKnight AJ, Maxwell AP. Genetics of new-onset diabetes after transplantation. J. Am. Soc. Nephrol. 25(5), 1037-1049 (2014)
28. Sahin DS, Tumer C, Demir C et al. Association with leptin gene C-2548 G>A polymorphism, serum leptin levels, and body mass index in Turkish obese patients. Cell. Biochem. Biophys. 65(2), 243-247 (2013)
29. Mammès O, Betoulle D, Aubert R, Herbeth B, Siest G, Fumeron F. Association of the G-2548Apolymorphism in the 5'region of the LEP gene with overweight. Ann. Hum. Genet. 64(5), 391-394 (2000)
30. Vaskú JA, Vaskú A, Dostálová Z, Bienert P. Association of leptin genetic polymorphism -2548 G/A with gestational diabetes mellitus. Genes. Nutr. 1(2), 117-123 (2006)
31. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm. Metab. Res. 34(7), 355-359 (2002)
32. Hegyi K, Fülöp K, Kovács K, Falus A. Leptin-induced signal transduction pathways. Cell. Biol. Int. 28(3), 159-169 (2004)
33. Lam NT, Cheung AT, Riedel MJ, Light PE, Cheeseman CI, Kieffer TJ. Leptin reduces glucose transport and cellular ATP levels in INS-1 beta-cells. J. Mol. Endocrinol. 32(2), 415-424 (2004)
34. Lee JW, Swick AG, Romsos DR. Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway. Exp. Biol. Med. (Maywood). 228(2), 175-182 (2003)
35. Sjöholm A. Inhibitory effects of cyclosporine A on rat insulinoma cell proliferation, polyamine content and insulin secretion. Mol. Cell. Endocrinol. 99(1), 21-24 (1994)
36. Drachenberg CB, Klassen DK, Weir MR et al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68(3), 396-402 (1999)
37. Li QY, Li F, Sun JH et al. Mechanisms of diabetes mellitus induced with FK506 in SD rats models. Immunopharmacol. Immunotoxicol. 31(4), 675-681 (2009)
38. zbay LA, Smidt K, Mortensen DM, Carstens J, Jrgensen KA, Rungby J. Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells. Br. J. Pharmacol. 162(1), 136-146 (2011)
39. Xu C, Niu YJ, Liu XJ et al. Tacrolimus reversibly reduces insulin secretion, induces insulin resistance, and causes islet cell damage in rats. Int. J. Clin. Pharmacol. Ther. 52(7), 620-627 (2014)
40. Pereira MJ, Palming J, Rizell M et al. Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents. J. Clin. Endocrinol. Metab. 99(10), E1885-E1894 (2014)